Brief: Gentian Q1 EBITDA Turns To Profit Of NOK 4.8 Mln
30/04/2024 07:15
April 30 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* RECORD SALES OF NOK 38.5 MILLION IN 1Q24, UP 22% VERSUS
1Q23
(19% ORGANIC GROWTH)
* EBITDA OF NOK 4.8 MILLION IN 1Q24 VERSUS NOK -0.5 MILLION
IN
1Q23
Source text for Eikon: ID:nObinRxcTa
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company